© 2026 TPM MEDIA LLC. ALL RIGHTS RESERVED.

Josh Kovensky

Investigative Reporter
Latest Contact
Josh Kovensky is an investigative reporter for Talking Points Memo, based in New York. He previously worked for the Kyiv Post in Ukraine, covering politics, business, and corruption there.
LATEST
WASHINGTON, DC - JANUARY 06: Protesters gather storm the Capitol and halt a joint session of the 117th Congress on Wednesday, Jan. 6, 2021 in Washington, DC. (Kent Nishimura / Los Angeles Times) WASHINGTON, DC - JANUARY 06: Protesters gather storm the Capitol and halt a joint session of the 117th Congress on Wednesday, Jan. 6, 2021 in Washington, DC. (Kent Nishimura / Los Angeles Times)
Impeachment Managers Plan To Home In On Trump’s Role In Insurrection On Thursday
02.11.21 | 10:00 am
In Interview With TPM, Jan. 6 Rally Organizer Ties Date Change To Trump Prime Badge
02.10.21 | 4:17 pm
NYT: Georgia Opens Criminal Probe Of Trump Election Meddling
02.10.21 | 11:00 am
NEW YORK, NY - JUNE 27: Donald Trump's former campaign chairman Paul Manafort, exiting his arraignment in New York County Criminal Court, plead not guilty to state mortgage fraud charges on June 27, 2019 in New York City. (Photo by Yana Paskova/Getty Images) NEW YORK, NY - JUNE 27: Donald Trump's former campaign chairman Paul Manafort, exiting his arraignment in New York County Criminal Court, plead not guilty to state mortgage fraud charges on June 27, 2019 in New York City. (Photo by Yana Paskova/Getty Images)
Manafort Walks After NY Court Declines To Resurrect State Prosecution
02.08.21 | 5:56 pm
WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images) WASHINGTON, DC - AUGUST 23: FDA Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, DC. The move by the FDA comes after President Trump accused the FDA of slow-walking the therapy to harm his reelection chances.(Photo by Pete Marovich/Getty Images)
Trump’s FDA Chief: More ‘Safeguards’ Needed Against Presidential Pressure
02.08.21 | 11:54 am
Biden Admin Uses Wartime Powers To Boost Fed Role In Vaccine Distribution
02.05.21 | 12:03 pm
WASHINGTON, DC - JANUARY 06: Protesters gather storm the Capitol and halt a joint session of the 117th Congress on Wednesday, Jan. 6, 2021 in Washington, DC. (Kent Nishimura / Los Angeles Times) WASHINGTON, DC - JANUARY 06: Protesters gather storm the Capitol and halt a joint session of the 117th Congress on Wednesday, Jan. 6, 2021 in Washington, DC. (Kent Nishimura / Los Angeles Times)
GOP Flirts With Notion That Fighting Extremism Is A Threat To Political Survival
02.04.21 | 5:46 pm
READ: House Impeachment Managers Want to Hear From Trump Directly
02.04.21 | 1:39 pm
In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP) In this photo Dec. 25, 2020 released by Xinhua News Agency, packages of COVID-19 inactivated vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP)
What A ‘Forever War’ Against COVID Would Mean Prime Badge
02.03.21 | 6:07 pm
COVID Threatens To Become New Forever War
02.03.21 | 2:30 pm

Contact

Email:
Signal: JoshKovensky.04
Bluesky: @joshkovensky.bsky.social
X:

Browse by Year